Curanex Pharmaceuticals announces pricing of its initial public offering

1 hour ago 1

Curanex Pharmaceuticals (NASDAQ:CURX) announced on Tuesday the pricing of its initial public offering of 3.75 million shares of common stock at a public offering price of $4.00 per share, for gross proceeds of $15 million, before deducting underwriting discounts and offering expenses.